Notably, missense MEGF10 mutations that affect protein folding or post-translational modifications but allow some MEGF10 function, underlie rare myopathies characterized by adult onset and minicores referred to as MEGF10-myopathies, being distinct from EMARDD [56]. Here, MEGF10 is linked to MEGF10-related myopathy.